← Eichor
Condition: Hepatitis E Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hepatitis E Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients
Phase 4 · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT05182463Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women
Phase 2 · 1 location(s) · International Vaccine Institute · NCT05808166Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region
Phase 2 · 8 location(s) · AusperBio Therapeutics Inc. · NCT07370207Study of AT-587 in Healthy Subjects
Phase 1 · 1 location(s) · Atea Pharmaceuticals, Inc. · NCT07728487Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children
Phase 2 · 3 location(s) · International Vaccine Institute · NCT06306196
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.